Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Sales26 43126 50523 00624 05624 78425 450
Operating income (EBITDA)9 4158 8838 0457 1687 7498 269
Operating profit (EBIT)8 3308 0156 5946 1536 2466 744
Pre-Tax Profit (EBT)6 6926 6472 9686 3264 0024 781
Net income4 5655 6282 7566 5952 5673 163
PER---9,2625,219,0
EPS (PNC)91,511156,714252,469,4
Dividend per Share (PNC)74,078,080,091,981,980,6
Yield5,61%5,91%6,06%6,97%6,21%6,10%
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Debt14 03712 64514 37711 08612 63812 817
Finance------
Operating income (EBITDA)9 4158 8838 0457 1687 7498 269
Leverage
(Debt/EBITDA)
1,49x1,42x1,79x1,55x1,63x1,55x
Capital Expenditure1 0511 1881 1881 9641 6851 460
Book Value Per Share (BVPS)120 PNC146 PNC87,6 PNC144 PNC124 PNC107 PNC
Cash Flow per Share87,7 PNC149 PNC108 PNC85,1 PNC106 PNC123 PNC
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 64 215 M GBP -
Entreprise Value (EV) 75 301 M GBP 76 853 M GBP
Valuation 2015e 2016e
PER (Price / EPS) 9,26x 25,2x
Capitalization / Revenue 2,67x 2,59x
EV / Revenue 3,13x 3,10x
EV / EBITDA 10,5x 9,92x
Yield (DPS / Price) 6,97% 6,21%
Price to book (Price / BVPS) 9,15x 10,6x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 25,6% 25,2%
operating Leverage (Delta EBIT / Delta Sales) - 0,50x
Net Margin (Net Profit / Revenue) 27,4% 10,4%
ROA (Net Profit / Asset) 14,8% 7,81%
ROE (Net Profit / Equities) 80,1% 66,3%
Rate of Dividend 64,5% 156%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   8,17% 6,80%
Cash Flow / Sales (Taux d'autofinancement) 17,2% 20,8%
Capital Intensity (Assets / Sales) 1,85x 1,33x
Financial Leverage (Net Debt / EBITDA) 1,55x 1,63x
Price Earning Ratio
EPS & Dividend